Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide
1.0.0 - ci-build
Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-ScreeningEligible | Version: 1.0.0 | |||
| Draft as of 2024-10-22 | Computable Name: flow-ScreeningEligible | |||
Copyright/Legal: (C) 2024 The MITRE Corporation. All Rights Reserved. Approved for Public Release: 24-2711. Distribution Unlimited. Unless otherwise noted, this work is available under an Apache 2.0 license. It was produced by the MITRE Corporation for the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention in accordance with the Statement of Work, contract number 75FCMC18D0047, task order number 75D30123F17931. |
||||
Determines whether a patient is eligible for routine breast cancer screening. This includes absolute exclusion criteria for which routine screening is not indicated in all guidelines and pathways.
Individuals who have certain signs or symptoms concerning for breast cancer or other breast diseases are excluded from routine screening pathways and should have diagnostic testing performed.
See here for logic path L2 representation.
| Id: | flow-ScreeningEligible | ||||||
|---|---|---|---|---|---|---|---|
| Url: | Screening Eligible | ||||||
| Version: | 1.0.0 | ||||||
| Title: | Screening Eligible | ||||||
| Status: | draft | ||||||
| Experimental: | true | ||||||
| Type: |
system: http://terminology.hl7.org/CodeSystem/plan-definition-type code: eca-rule |
||||||
| Date: | 2024-10-22 | ||||||
| Publisher: | MITRE | ||||||
| Description: | Determines whether a patient is eligible for routine breast cancer screening. This includes absolute exclusion criteria for which routine screening is not indicated in all guidelines and pathways. Individuals who have certain signs or symptoms concerning for breast cancer or other breast diseases are excluded from routine screening pathways and should have diagnostic testing performed. |
||||||
| Knowledge Capability: | executable | ||||||
| Knowledge Representation Level: | structured | ||||||
| Copyright: | (C) 2024 The MITRE Corporation. All Rights Reserved. Approved for Public Release: 24-2711. Distribution Unlimited. Unless otherwise noted, this work is available under an Apache 2.0 license. It was produced by the MITRE Corporation for the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention in accordance with the Statement of Work, contract number 75FCMC18D0047, task order number 75D30123F17931. |
||||||
| Approval Date: | 2024-10-22 | ||||||
| Libraries: |
|
||||||
| Actions: |
|